Diabetes

Showing NaN - NaN of 123

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Glimepiride)

Completed
  • Diabetes
  • Birmingham, Alabama
  • +83 more
Jun 22, 2020

Stroke, Myocardial Infarction, Diabetes Trial in Worldwide (pioglitazone, )

Completed
  • Stroke
  • +2 more
  • Birmingham, Alabama
  • +182 more
Apr 14, 2020

Diabetes Trial in United States (Guardian® blood-sugar monitoring device)

Terminated
  • Diabetes
  • Guardian® blood-sugar monitoring device
  • Dallas, Texas
  • +5 more
Mar 6, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +118 more
Feb 14, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tuscumbia, Alabama
  • +116 more
Feb 14, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Canagliflozin, Placebo (canagliflozin))

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anaheim, California
  • +118 more
Jan 8, 2020

Acute Ischemic Stroke, Diabetes, Hyperglycemia Trial in United States (IV insulin to maintain target glucose concentration of

Completed
  • Acute Ischemic Stroke
  • +2 more
  • IV insulin to maintain target glucose concentration of 80-130 mg/dL
  • Standard Care control - sliding scale insulin to keep glucose less than 180 mg/dL
  • Tucson, Arizona
  • +69 more
Dec 13, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Muscle Shoals, Alabama
  • +142 more
Nov 8, 2019

Lucica ® Glycated Albumin-L Clinical Program - Pivotal Study

Completed
  • Diabetes
    • Los Angeles, California
    • +7 more
    Nov 1, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • insulin aspart
    • Encino, California
    • +91 more
    Nov 12, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec/insulin aspart, Insulin glargine, Insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Insulin degludec/insulin aspart
    • +2 more
    • Glendale, Arizona
    • +70 more
    Nov 8, 2019

    Diabetes, Type 2, Diabetes Trial in Dallas (Metformin, Detemir, Liraglutide)

    Completed
    • Diabetes Mellitus, Type 2
    • Diabetes
    • Dallas, Texas
      UT Southwestern Medical Center
    Oct 1, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, Dulaglutide)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Tuscumbia, Alabama
    • +208 more
    Oct 2, 2019

    Chronic Kidney Disease, Diabetes, Hypertension Trial in Farmington, Arlington, Dallas (Collaborative Model of Primary care and

    Completed
    • Chronic Kidney Disease
    • +4 more
    • Collaborative Model of Primary care and Subspecialty care
    • Farmington, Connecticut
    • +3 more
    Oct 10, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +149 more
    Jul 30, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • insulin degludec
    • insulin glargine
    • Birmingham, Alabama
    • +445 more
    Jul 10, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Alabaster, Alabama
    • +427 more
    Jul 3, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +252 more
    Jun 20, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin degludec, insulin detemir, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • insulin degludec
    • +2 more
    • Little Rock, Arkansas
    • +80 more
    Jun 3, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anniston, Alabama
    • +145 more
    May 28, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +230 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin detemir, insulin aspart)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Mobile, Alabama
    • +190 more
    May 28, 2019

    Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 1
    • Faster-acting insulin aspart
    • +2 more
    • Tucson, Arizona
    • +151 more
    May 28, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Anniston, Alabama
    • +85 more
    May 28, 2019

    Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

    Completed
    • Diabetes
    • Diabetes Mellitus, Type 2
    • Phoenix, Arizona
    • +98 more
    May 28, 2019